International Journal of Phytomedicine and Phytotherapy
Treatment groups | RBC (106 cells /mL) | Hb (g/dL) | MCV (fi) | HCT (%) | WBC (103 cells /ml) | MCH (pg) | MCHC (g/dL) | Platelet (106 cells /mL) |
---|---|---|---|---|---|---|---|---|
Normal Control | 8.4 ± 0.1a | 16.9 ± 0.7a | 54.3 ± 1.3a | 46.0 ± 0.9a | 8.9 ± 0.4 | 20.2 ± 0.1a | 37.2 ± 0.4 | 669.3 ± 43.6 |
Diabetic Control | 7.7 ± 0.1c | 15.3 ± 0.5b | 53.4 ± 1.0ab | 41.2 ± 0.7b | 5.3 ± 0.3 | 19.9 ± 0.1ab | 37.2 ± 0.2 | 535.2 ± 17.9 |
CTE I | 8.3 ± 0.1ab | 16.2 ± 0.3ab | 52.3 ± 0.5b | 42.9 ± 0.4ab | 5.9 ± 0.2 | 19.6 ± 0.1b | 37.5 ± 0.1 | 613.2 ± 19.4 |
CTE II | 7.6 ± 0.1c | 15.1 ± 0.4b | 52.4 ± 0.6b | 39.7 ± 0.5b | 6.8 ± 0.2 | 20.0 ± 0.1ab | 38.2 ± 0.2 | 649.8 ± 36.4 |
Glibenclamide positive control | 7.8 ± 0.2bc | 15.8 ± 0.4ab | 52.3 ± 1.1b | 40.1 ± 1.4b | 7.6 ± 0.6 | 19.7 ± 0.1b | 37.1 ± 0.4 | 593.6 ± 72.4 |